Notably, this correlation exists independently of PNPLA3, TM6SF2, and MBOAT7, with a stronger association for NAFLD/ALD cirrhosis than other risk factors [89,96]. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.